It is no wonder that hs-CRP is a non-invasive complementary marker of NAFLD, and its high levels are common in this population due to the interplay between fatty liver and cardiometabolic problems (51). Here, MAP3K14 is linked to metabolic dysfunction-associated steatotic liver disease.